LTD4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Asthma, Pneumonia and Allergic asthma. The involved functions are known as inhibitors, Signal Transduction, Cell Survival, antagonists and Phosphorylation. Ltd4 often locates in Membrane, Tissue membrane, Protoplasm, Cytoplasmic matrix and membrane fraction. The associated genes with LTD4 are ALOX5 gene, UMOD gene, P4HTM gene, RAF1 gene and Homologous Gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of LTD4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTD4?

LTD4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Allergic asthma, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTD4

MeSH term MeSH ID Detail
Respiratory Hypersensitivity D012130 18 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Enteritis D004751 8 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Carotid Stenosis D016893 15 associated lipids
Influenza, Human D007251 11 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with LTD4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTD4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTD4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTD4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTD4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTD4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTD4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTD4

Download all related citations
Per page 10 20 50 100 | Total 640
Authors Title Published Journal PubMed Link
Sugahara S et al. Kinins are involved in the development of allergic nasal hyperresponsiveness in guinea pigs. 2003 Eur. J. Pharmacol. pmid:12969770
Rehn M and Diener M Cysteinyl leukotrienes mediate the response of submucosal ganglia from rat colon to bradykinin. 2012 Eur. J. Pharmacol. pmid:22366210
Yoshikawa S et al. Modulation of acetylcholine release from the myenteric plexus of guinea-pig ileum by 5-lipoxygenase metabolites of arachidonic acid. 1993 Eur. J. Pharmacol. pmid:8223906
Tudhope SR et al. BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes. 1994 Eur. J. Pharmacol. pmid:7698171
Bäck M et al. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum. 1996 Eur. J. Pharmacol. pmid:8982726
Ohbayashi H et al. Compared effects of natriuretic peptides on ovalbumin-induced asthmatic model. 1998 Eur. J. Pharmacol. pmid:9617752
Rehni AK et al. Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. 2008 Eur. J. Pharmacol. pmid:18840427
Mizutani N et al. Effect of TA-270, a novel quinolinone derivative, on antigen-induced nasal blockage in a guinea pig model of allergic rhinitis. 2009 Eur. J. Pharmacol. pmid:19022242
Dahlén SE Treatment of asthma with antileukotrienes: first line or last resort therapy? 2006 Eur. J. Pharmacol. pmid:16510137
Hattori T et al. Effects of H2O2 on membrane potential of smooth muscle cells in rabbit mesenteric resistance artery. 2003 Eur. J. Pharmacol. pmid:12620501
Hori M et al. NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects. 2009 Eur. J. Pharmacol. pmid:19616537
Sakata K and Bäck M Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma. 2002 Eur. J. Pharmacol. pmid:11834255
Sakai H et al. Augmented venous responsiveness to leukotriene D(4) in nasal septal mucosae of repeatedly antigen-challenged rats. 2010 Eur. J. Pharmacol. pmid:20638382
Tsopanoglou NE et al. Leukotrienes C4 and D4 promote angiogenesis via a receptor-mediated interaction. 1994 Eur. J. Pharmacol. pmid:7523148
Takami M and Tsukada W Effect of DP-1904, a thromboxane synthetase inhibitor, on antigen- and spasmogen-induced bronchoconstriction in rodents. 1999 Eur. J. Pharmacol. pmid:10082207
Mizutani N et al. Involvement of peroxynitrite in pollen-induced nasal blockage in guinea pigs. 2008 Eur. J. Pharmacol. pmid:18191833
Arakawa H et al. Effect of maturation on airway plasma exudation induced by eicosanoids in guinea pig. 1994 Eur. J. Pharmacol. pmid:7982451
Neves JS et al. Evaluating the prophylactic potential of the phtalimide derivative LASSBio 552 on allergen-evoked inflammation in rats. 2005 Eur. J. Pharmacol. pmid:15792791
Ferrari F et al. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity. 2004 Eur. J. Pharmacol. pmid:15541426
Bäck M et al. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes. 2000 Eur. J. Pharmacol. pmid:10936497
Kumasawa F et al. Apoptosis signal-regulating kinase 1 in leukotriene D(4)-induced activator protein-1 activation in airway smooth muscle cells. 2005 Eur. J. Pharmacol. pmid:15970283
Bäck M et al. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes. 2000 Eur. J. Pharmacol. pmid:10936498
Gorenne I et al. Antagonism of leukotriene responses in human airways by BAY x7195. 1995 Eur. J. Pharmacol. pmid:7796856
Saegusa S et al. Leukotriene D(4)-induced Rho-mediated actin reorganization in human bronchial smooth muscle cells. 2001 Eur. J. Pharmacol. pmid:11226389
Diener M and Scharrer E The leukotriene D4 receptor blocker, SK&F 104353, inhibits volume regulation in isolated crypts from the rat distal colon. 1993 Eur. J. Pharmacol. pmid:8405093
Stengel PW et al. Inhaled anandamide reduces leukotriene D4-induced airway obstruction in guinea pigs. 2007 Eur. J. Pharmacol. pmid:17166495
Fernandez J et al. Isoquercitrin from Argemone platyceras inhibits carbachol and leukotriene D4-induced contraction in guinea-pig airways. 2005 Eur. J. Pharmacol. pmid:16202993
Tamaoka M et al. The epidermal growth factor receptor mediates allergic airway remodelling in the rat. 2008 Eur. Respir. J. pmid:18653647
Ishikawa J et al. Involvement of endogenous tachykinins in LTD4-induced airway responses. 1996 Eur. Respir. J. pmid:8730008
Kubes P Nitric oxide and microvascular permeability: a continuing dilemma. 1997 Eur. Respir. J. pmid:9032483
Kageyama N et al. Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators. 1997 Eur. Respir. J. pmid:9032485
Meliton AY et al. Leukotriene D4 activates {beta}2-integrin adhesion in human polymorphonuclear leukocytes. 2010 Eur. Respir. J. pmid:19679609
Diamant Z et al. Effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responsiveness to leukotriene D4 in normal and asthmatic subjects. 1994 Eur. Respir. J. pmid:8013602
Dahlén B et al. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics. 1994 Eur. Respir. J. pmid:8162986
Casas A et al. Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor. 2005 Eur. Respir. J. pmid:16135725
Salim T et al. The inflammatory mediator leukotriene D₄ induces subcellular β-catenin translocation and migration of colon cancer cells. 2014 Exp. Cell Res. pmid:24211746
Massoumi R et al. Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin E2 and upregulation of alpha2beta1-integrin. 2003 Exp. Cell Res. pmid:14499635
Thodeti CK et al. The epsilon isoform of protein kinase C is involved in regulation of the LTD(4)-induced calcium signal in human intestinal epithelial cells. 2001 Exp. Cell Res. pmid:11139333
Nielsen CK et al. Leukotriene D4 activates distinct G-proteins in intestinal epithelial cells to regulate stress fibre formation and to generate intracellular Ca2+ mobilisation and ERK1/2 activation. 2005 Exp. Cell Res. pmid:15541723
Ramos-Ramírez P et al. Antigen-induced airway hyperresponsiveness in absence of broncho-obstruction in sensitized guinea pigs. 2013 Exp. Lung Res. pmid:23527782
Ochsner M The action of the peptidoleukotriene LTD4 on intracellular calcium in rat mesangial cells. 1996 Experientia pmid:8841513
Sparatore A and Sparatore F Preparation and pharmacological activities of 10-homolupinanoyl-2-R-phenothiazines. 1994 Farmaco pmid:7910463
Sparatore A and Sparatore F Synthesis and preliminary pharmacological investigation of some 2-[4-(dialkylaminoalkoxy)phenyl]benzotriazoles and their N-oxides. 1998 Farmaco pmid:9604317
McMahon B et al. Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. 2002 FASEB J. pmid:12223454
Claesson HE et al. Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical Hodgkin lymphoma. 2008 FEBS J. pmid:18647347
Tanaka T et al. Protective effect of peptide leukotriene antagonist on renal failure induced by a tourniquet in rabbits. 1995 Forensic Sci. Int. pmid:7875619
Kelley M et al. Induction of peroxisomal enzymes by a tetrazole-substituted 2-quinolinylmethoxy leukotriene D4 antagonist. 1994 Fundam Appl Toxicol pmid:7982537
Bonnefoi MS et al. Subchronic toxicity studies with the leukotriene D4 antagonist RG 12525. 1995 Fundam Appl Toxicol pmid:8566477
Martin CA et al. In vitro pharmacological effects of S 12370 (2-[4-benzhydryloxypiperidinoethyl]isoxindole; an antibronchoconstrictor agent) in normal and sensitized tissue. 1996 Fundam Clin Pharmacol pmid:8902549
Honda I et al. Tachykinin antagonist FK224 inhibits neurokinin A-, substance P- and capsaicin-induced human bronchial contraction. 1997 Fundam Clin Pharmacol pmid:9243258